Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Stockholder Note Receivable
Retained Earnings/(Deficit)
Retained Earnings/(Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2018     137,250            
Balance at Dec. 31, 2018 $ 1,599,878 $ 7,936 $ 1,373 $ 1,376,880 $ (20,000) $ 250,517 $ 7,936 $ (9,446) $ 554
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income 30,049         30,025     24
Other comprehensive income (loss) 4,794             4,794  
Share-based compensation 24,152     24,152          
Stockholder note receivable 1,263     (3,737) 5,000        
Common stock issuance, net (in shares)     4,346            
Common stock issuance, net 105,266   $ 43 105,223          
Purchases of stock options (23,155)     (23,155)          
Acquisition of noncontrolling interest 0     578         (578)
Balance (in shares) at Dec. 31, 2019     141,596            
Balance at Dec. 31, 2019 1,750,183   $ 1,416 1,479,941 (15,000) 288,478   (4,652) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income (360,192)         (360,192)      
Other comprehensive income (loss) 1,422             1,422  
Common stock issuance, net (in shares)     3,600            
Common stock issuance, net $ 90,000   $ 36 89,964          
Balance (in shares) at Dec. 31, 2020 145,196   145,196            
Balance at Dec. 31, 2020 $ 1,481,413   $ 1,452 1,569,905 (15,000) (71,714)   (3,230) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net (loss) income (579,369)         (579,369)      
Other comprehensive income (loss) 214             214  
Share-based compensation 334,339     334,339          
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 3,843     3,843          
Stockholder note receivable 0     (15,000) 15,000        
Common stock issuance, net (in shares)     40,582            
Common stock issuance, net 701,367   $ 406 700,961          
Issuance of common stock in connection with Series A Preferred Stock conversion 149,585   $ 67 149,518          
Issuance of common stock in connection with Series A Preferred Stock conversion (in shares)     6,687            
Issuance of restricted stock in connection with restricted Series A Preferred Stock conversion $ 0   $ 6 (6)          
Issuance of restricted stock in connection with restricted Series A Preferred Stock conversion (in shares)     595            
Balance (in shares) at Dec. 31, 2021 193,060   193,060            
Balance at Dec. 31, 2021 $ 2,091,392   $ 1,931 $ 2,743,560 $ 0 $ (651,083)   $ (3,016) $ 0